|
๐
|
Aggresome induction by proteasome inhibitor bortezomib and alpha-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cells.
11 auth.
L. Catley,
E. Weisberg,
T. Kiziltepe,
Y. Tai,
T. Hideshima,
P. Neri,
...
P. Tassone,
P. Atadja,
D. Chauhan,
N. Munshi,
K. Anderson
|
8 |
2006 |
8
๐
|
|
๐
|
HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells.
14 auth.
E. Carbone,
P. Neri,
M. Mesuraca,
M. Fulciniti,
T. Otsuki,
D. Pende,
V. Groh,
T. Spies,
G. Pollio,
D. Cosman,
...
L. Catalano,
P. Tassone,
B. Rotoli,
S. Venuta
|
8 |
2005 |
8
๐
|
|
๐
|
A large meta-analysis establishes the role of MRD negativity in long-term survival outcomes in patients with multiple myeloma.
16 auth.
N. Munshi,
H. Avet-Loiseau,
K. Anderson,
P. Neri,
B. Paiva,
M. Samur,
M. Dimopoulos,
M. Kulakova,
A. Lam,
M. Hashim,
...
Jianming He,
B. Heeg,
J. Ukropec,
J. Vermeulen,
S. Cรดtรฉ,
N. Bahlis
|
8 |
2020 |
8
๐
|
|
๐
|
Dysfunctional T regulatory cells in multiple myeloma.
12 auth.
R. Prabhala,
P. Neri,
J. Bae,
P. Tassone,
M. Shammas,
C. Allam,
...
J. Daley,
D. Chauhan,
E. Blanchard,
H. Thatte,
K. Anderson,
N. Munshi
|
7 |
2006 |
7
๐
|
|
๐
|
Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.
14 auth.
Y. Tai,
Xian-Feng Li,
I. Breitkreutz,
Weihua Song,
P. Neri,
L. Catley,
K. Podar,
T. Hideshima,
D. Chauhan,
N. Raje,
...
R. Schlossman,
P. Richardson,
N. Munshi,
K. Anderson
|
7 |
2006 |
7
๐
|
|
๐
|
Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications.
13 auth.
M. Shammas,
P. Neri,
Hemanta Koley,
R. Batchu,
R. Bertheau,
Vidit N. Munshi,
R. Prabhala,
M. Fulciniti,
Y. Tai,
S. Treon,
...
R. Goyal,
K. Anderson,
N. Munshi
|
7 |
2006 |
7
๐
|
|
๐
|
A novel carbohydrate-based therapeutic GCS-100 overcomes bortezomib resistance and enhances dexamethasone-induced apoptosis in multiple myeloma cells.
12 auth.
D. Chauhan,
Guilan Li,
K. Podar,
T. Hideshima,
P. Neri,
De-Liu He,
...
N. Mitsiades,
P. Richardson,
Yan Chang,
J. Schindler,
Bradley J. Carver,
K. Anderson
|
7 |
2005 |
7
๐
|
|
๐
|
Targeting mitochondrial factor Smac/DIABLO as therapy for multiple myeloma (MM).
15 auth.
D. Chauhan,
P. Neri,
Mugdha Velankar,
K. Podar,
T. Hideshima,
M. Fulciniti,
P. Tassone,
N. Raje,
C. Mitsiades,
N. Mitsiades,
...
P. Richardson,
L. Zawel,
Mary A. Tran,
N. Munshi,
K. Anderson
|
7 |
2004 |
7
๐
|
|
๐
|
Cytotoxic activity of the maytansinoid immunoconjugate B-B4-DM1 against CD138+ multiple myeloma cells.
16 auth.
P. Tassone,
V. Goldmacher,
P. Neri,
A. Gozzini,
M. Shammas,
K. Whiteman,
L. Hylander-Gans,
D. Carrasco,
T. Hideshima,
R. Shringarpure,
...
Jialan Shi,
C. Allam,
J. Wijdenes,
S. Venuta,
N. Munshi,
K. Anderson
|
7 |
2004 |
7
๐
|
|
๐ฆ
|
Bortezomib-induced "BRCAness" sensitizes multiple myeloma cells to PARP inhibitors.
13 auth.
P. Neri,
Li Ren,
K. Gratton,
Erin Stebner,
Jordan T. Johnson,
A. Klimowicz,
P. Duggan,
P. Tassone,
A. Mansoor,
D. Stewart,
...
S. Lonial,
L. Boise,
N. Bahlis
|
7 |
2010 |
7
๐ฆ
|
|
๐ฆ
|
Integrin ฮฒ7-mediated regulation of multiple myeloma cell adhesion, migration, and invasion.
14 auth.
P. Neri,
Li Ren,
A. Azab,
Matthew Brentnall,
K. Gratton,
A. Klimowicz,
Charles P. Lin,
P. Duggan,
P. Tassone,
A. Mansoor,
...
D. Stewart,
L. Boise,
I. Ghobrial,
N. Bahlis
|
7 |
2011 |
7
๐ฆ
|
